Global Structural Heart Devices Market Forecast up to 2024
Global Structural Heart Devices Market – Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
Overview: Structural heart disease are the abnormalities in the heart by birth or which develop later in life because of aging, infections, or injury, which leads to heart attacks and other underlying ailments. The term structural heart disease involves a range of ailments linked with congestive heart failure (CHF) and embolic stroke, together with atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO) and left atrial appendix (LAA).
Increasing aging population, increasing prevalence of cardiovascular diseases, and increase in minimally invasive surgery for structural heart diseases are the factors aiding for the growth of the structural heart devices market. Increase healthcare spending, increase in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the market growth. However, lack of skilled healthcare professionals and stringent regulatory approval process are hampering the market growth.
Market Analysis: The “Global Structural Heart Devices Market” is estimated to witness a CAGR of 10.2% during the forecast period 2018–2024. The structural heart devices market is analyzed based on three segments – Type, End Users, and Regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the structural heart devices market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth in 2017.
Type Analysis: Based on the type, the market is segmented into structural heart repair devices and structural heart replacement devices. The major share holder of the market are structural heart replacement devices and is also the fastest growing segment in the market.
End Users Analysis: Based on the end users, the market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals are the largest among end-users and are preferred for the treatment due to the advantages such as availability of surgery specialists, reimbursement facility, and availability of high end equipment for the surgery.
Key Players: The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edward LifeSciences Corp., and LivaNova PLC. Lepu Medical Technology, CryoLife, Inc., JenaValve Technologies GmbH, TTK Healthcare, and Braile Biomedica, are the key other key players in the market.
Competitive Analysis: Mergers and acquisitions has been the major strategy followed by major players in the market to maintain their leadership in the market. Edwards congealed its position in the mitral valve market by buying the Harpoon Medical, the DMR-focused chordal surgical mitral valve repair startup company for ~$100M upfront. Many players in the market are flooding into the TMVR arena, the market can expect strong and innovative state-of-the-art technologies, creating intense competition in the future. A Canadian company, NeoVasc has developed a novel technology device named Tiara to replace any regurgitation of mitral valves. However, these devices have not gained approval yet and as such are lagging far behind the MitraClip. As a result, Abbott Vascular will have many years to solidify its place as the market leader in TMVR solutions.
Benefits: The report provides complete details about the usage and adoption rate of structural heart devices in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Overview: Structural heart disease are the abnormalities in the heart by birth or which develop later in life because of aging, infections, or injury, which leads to heart attacks and other underlying ailments. The term structural heart disease involves a range of ailments linked with congestive heart failure (CHF) and embolic stroke, together with atrial septal defect (ASD), ventricular septal defect (VSD), patent foramen ovale (PFO) and left atrial appendix (LAA).
Increasing aging population, increasing prevalence of cardiovascular diseases, and increase in minimally invasive surgery for structural heart diseases are the factors aiding for the growth of the structural heart devices market. Increase healthcare spending, increase in the number of outpatient procedures, and market expansion opportunities in emerging nations are providing an opportunity for the market growth. However, lack of skilled healthcare professionals and stringent regulatory approval process are hampering the market growth.
Market Analysis: The “Global Structural Heart Devices Market” is estimated to witness a CAGR of 10.2% during the forecast period 2018–2024. The structural heart devices market is analyzed based on three segments – Type, End Users, and Regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the structural heart devices market, followed by Europe, Asia Pacific, and Rest of the World. More than 40% of the market is occupied by North America, with the US being the major contributor to the market growth in 2017.
Type Analysis: Based on the type, the market is segmented into structural heart repair devices and structural heart replacement devices. The major share holder of the market are structural heart replacement devices and is also the fastest growing segment in the market.
End Users Analysis: Based on the end users, the market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals are the largest among end-users and are preferred for the treatment due to the advantages such as availability of surgery specialists, reimbursement facility, and availability of high end equipment for the surgery.
Key Players: The major players in the market are Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Edward LifeSciences Corp., and LivaNova PLC. Lepu Medical Technology, CryoLife, Inc., JenaValve Technologies GmbH, TTK Healthcare, and Braile Biomedica, are the key other key players in the market.
Competitive Analysis: Mergers and acquisitions has been the major strategy followed by major players in the market to maintain their leadership in the market. Edwards congealed its position in the mitral valve market by buying the Harpoon Medical, the DMR-focused chordal surgical mitral valve repair startup company for ~$100M upfront. Many players in the market are flooding into the TMVR arena, the market can expect strong and innovative state-of-the-art technologies, creating intense competition in the future. A Canadian company, NeoVasc has developed a novel technology device named Tiara to replace any regurgitation of mitral valves. However, these devices have not gained approval yet and as such are lagging far behind the MitraClip. As a result, Abbott Vascular will have many years to solidify its place as the market leader in TMVR solutions.
Benefits: The report provides complete details about the usage and adoption rate of structural heart devices in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.2 Total Addressable Market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.2.1 Symptoms of Structural Heart Disease
3.3 Industry Trends
3.4 Related Markets
3.4.1 Cardiovascular Drugs
3.4.1.1 Trends of the Cardiovascular Drugs Market
3.4.2 Cardiovascular Diagnostics
3.4.3 Prosthetic Heart Valves
4 MARKET OUTLOOK
4.1 Reimbursement
4.2 Porter 5 (Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increase in Minimally Invasive Surgery for Structural Heart Diseases
5.3.1.2 Increasing prevalence of cardiovascular diseases
5.3.1.3 Increasing Aging Population
5.3.2 Restraints
5.3.2.1 Stringent Regulatory Approval Process
5.3.2.2 Lack of skilled healthcare professionals
5.3.3 Opportunities
5.3.3.1 Increase in healthcare spending
5.3.3.2 Increase in the number of outpatient procedures
5.3.3.3 Market expansion opportunities in emerging nations
5.3.4 DRO – Impact Analysis
5.4 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Structural Heart Repair Devices
6.2.1 Surgical Heart Repair Devices
6.2.2 Transcatheter Heart Repair Devices
6.3 Structural Heart Replacement Devices
6.3.1 Surgical Heart Replacement Devices
6.3.2 Transcatheter Heart Replacement Devices
7 END USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Center
7.4 Cardiac Centers
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Overview
8.3 Europe
8.3.1 Overview
8.4 Asia Pacific
8.4.1 Overview
8.5 Rest of the World
8.5.1 Overview
9 COMPETITIVE LANDSCAPE
10 VENDORS PROFILE
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Boston Scientific Corp.
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Presence
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Medtronic Plc
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Edwards Lifesciences Corp
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 LivaNova PLC
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Lepu Medical Technology Co., Ltd.
11.1.1 Overview
11.1.2 Key Highlights
11.2 CryoLife, Inc
11.2.1 Overview
11.2.2 Key Highlights
11.3 JenaValve Technology GmbH
11.3.1 Overview
11.3.2 Key Highlights
11.4 TTK Healthcare Ltd.
11.4.1 Overview
11.4.2 Key Highlights
11.5 Braile Biomedica
11.5.1 Overview
Annexure
Acronyms
1.1 Industry Overview
1.2 Total Addressable Market
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market (SAM)
3.2.1 Symptoms of Structural Heart Disease
3.3 Industry Trends
3.4 Related Markets
3.4.1 Cardiovascular Drugs
3.4.1.1 Trends of the Cardiovascular Drugs Market
3.4.2 Cardiovascular Diagnostics
3.4.3 Prosthetic Heart Valves
4 MARKET OUTLOOK
4.1 Reimbursement
4.2 Porter 5 (Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increase in Minimally Invasive Surgery for Structural Heart Diseases
5.3.1.2 Increasing prevalence of cardiovascular diseases
5.3.1.3 Increasing Aging Population
5.3.2 Restraints
5.3.2.1 Stringent Regulatory Approval Process
5.3.2.2 Lack of skilled healthcare professionals
5.3.3 Opportunities
5.3.3.1 Increase in healthcare spending
5.3.3.2 Increase in the number of outpatient procedures
5.3.3.3 Market expansion opportunities in emerging nations
5.3.4 DRO – Impact Analysis
5.4 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Structural Heart Repair Devices
6.2.1 Surgical Heart Repair Devices
6.2.2 Transcatheter Heart Repair Devices
6.3 Structural Heart Replacement Devices
6.3.1 Surgical Heart Replacement Devices
6.3.2 Transcatheter Heart Replacement Devices
7 END USERS: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Surgical Center
7.4 Cardiac Centers
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Overview
8.3 Europe
8.3.1 Overview
8.4 Asia Pacific
8.4.1 Overview
8.5 Rest of the World
8.5.1 Overview
9 COMPETITIVE LANDSCAPE
10 VENDORS PROFILE
10.1 Abbott Laboratories
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Boston Scientific Corp.
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Presence
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Medtronic Plc
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Edwards Lifesciences Corp
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 LivaNova PLC
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Lepu Medical Technology Co., Ltd.
11.1.1 Overview
11.1.2 Key Highlights
11.2 CryoLife, Inc
11.2.1 Overview
11.2.2 Key Highlights
11.3 JenaValve Technology GmbH
11.3.1 Overview
11.3.2 Key Highlights
11.4 TTK Healthcare Ltd.
11.4.1 Overview
11.4.2 Key Highlights
11.5 Braile Biomedica
11.5.1 Overview
Annexure
Acronyms
LIST OF TABLES
Table 1 TOP ACQUISITIONS IN CARDIOVASCULAR INDUSTRY
Table 2 STRUCTURAL HEART DEVICES MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION)
Table 3 ANNULOPLASTY RINGS AVERAGE PRICES
Table 4 HEART VALVE, MECHANICAL AVERAGE SELLING PRICE
Table 5 HEART VALVE AVERAGE PRICES
Table 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
Table 8 BOSTON SCIENTIFIC CORP.: OFFERINGS
Table 9 BOSTON SCIENTIFIC CORP: RECENT DEVELOPMENTS
Table 10 MEDTRONIC PLC: OFFERINGS
Table 11 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 12 EDWARD LIFESCIENCES CORP: OFFERINGS
Table 13 EDWARD LIFESCIENCES CORP: RECENT DEVELOPMENTS
Table 14 LIVANOVA PLC: OFFERINGS
Table 15 LIVANOVA PLC: RECENT DEVELOPMENTS
Table 16 LEPU MEDICAL TECHNOLOGY CO., LTD.: OVERVIEW
Table 17 LEPU MEDICAL TECHNOLOGY CO., LTD.: RECENT DEVELOPMENTS
Table 18 CRYOLIFE, INC.: OVERVIEW
Table 19 CRYOLIFE, INC.: RECENT DEVELOPMENTS
Table 20 JENAVALVE TECHNOLOGY GMBH.: OVERVIEW
Table 21 JENAVALVE TECHNOLOGY GMBH.: RECENT DEVELOPMENTS
Table 22 TTK HEALTHCARE LTD.: OVERVIEW
Table 23 TTK HEALTHCARE LTD.: RECENT DEVELOPMENTS
Table 24 BRAILE BIOMEDICA.: OVERVIEW
Table 25 BRAILE BIOMEDICA.: RECENT DEVELOPMENTS
Table 1 TOP ACQUISITIONS IN CARDIOVASCULAR INDUSTRY
Table 2 STRUCTURAL HEART DEVICES MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION)
Table 3 ANNULOPLASTY RINGS AVERAGE PRICES
Table 4 HEART VALVE, MECHANICAL AVERAGE SELLING PRICE
Table 5 HEART VALVE AVERAGE PRICES
Table 6 ABBOTT LABORATORIES: PRODUCT OFFERINGS
Table 7 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
Table 8 BOSTON SCIENTIFIC CORP.: OFFERINGS
Table 9 BOSTON SCIENTIFIC CORP: RECENT DEVELOPMENTS
Table 10 MEDTRONIC PLC: OFFERINGS
Table 11 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 12 EDWARD LIFESCIENCES CORP: OFFERINGS
Table 13 EDWARD LIFESCIENCES CORP: RECENT DEVELOPMENTS
Table 14 LIVANOVA PLC: OFFERINGS
Table 15 LIVANOVA PLC: RECENT DEVELOPMENTS
Table 16 LEPU MEDICAL TECHNOLOGY CO., LTD.: OVERVIEW
Table 17 LEPU MEDICAL TECHNOLOGY CO., LTD.: RECENT DEVELOPMENTS
Table 18 CRYOLIFE, INC.: OVERVIEW
Table 19 CRYOLIFE, INC.: RECENT DEVELOPMENTS
Table 20 JENAVALVE TECHNOLOGY GMBH.: OVERVIEW
Table 21 JENAVALVE TECHNOLOGY GMBH.: RECENT DEVELOPMENTS
Table 22 TTK HEALTHCARE LTD.: OVERVIEW
Table 23 TTK HEALTHCARE LTD.: RECENT DEVELOPMENTS
Table 24 BRAILE BIOMEDICA.: OVERVIEW
Table 25 BRAILE BIOMEDICA.: RECENT DEVELOPMENTS
LIST OF CHARTS
Chart 1 GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE, 2017 ($BILLION)
Chart 2 RESEARCH METHODOLOGY OF GLOBAL STRUCTURAL HEART DEVICES MARKET
Chart 3 STRUCTURAL HEART DEVICES MARKET REVENUE, 2017-2024 ($MILLION)
Chart 4 PORTERS 5 FORCES ON STRUCTURAL HEART DEVICES MARKET
Chart 6 STRUCTURAL HEART DEVICES MARKET SEGMENTATION
Chart 7 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
Chart 8 DRO - IMPACT ANALYSIS OF STRUCTURAL HEART DEVICES MARKET
Chart 9 KEY STAKEHOLDERS OF STRUCTURAL HEART DEVICES MARKET
Chart 10 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION)
Chart 11 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION)
Chart 12 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION)
Chart 13 STRUCTURAL HEART REPLACEMENT DEVICE MARKET REVENUE, BY TYPE 2017-2024 ($MILLION)
Chart 14 STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION)
Chart 15 SURGICAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 (%)
TRANSCATHETER VALVES
Chart 16 TRANSCATHETER VALVE REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION)
Chart 17 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY END USERS, 2017 (%)
Chart 18 STRUCTURAL HEART DEVICES MARKET BY REGIONAL SEGMENTATION, 2017 (%)
Chart 19 STRUCTURAL HEART DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION)
Chart 20 STRUCTURAL HEART DEVICES MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION)
Chart 21 STRUCTURAL HEART DEVICES MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION)
Chart 22 STRUCTURAL HEART DEVICES REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION)
Chart 23 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 24 ABBOTT LABORATORIES: BUSINESS UNITS
Chart 25 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
Chart 26 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 27 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 28 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS
Chart 29 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 30 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS
Chart 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 32 MEDTRONIC PLC: BUSINESS UNITS
Chart 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 34 MEDTRONIC PLC: SWOT ANALYSIS
Chart 35 EDWARD LIFESCIENCES CORP: OVERVIEW SNAPSHOT
Chart 36 EDWARD LIFESCIENCES CORP: BUSINESS UNITS
Chart 37 EDWARD LIFESCIENCES CORP: GEOGRAPHIC PRESENCE
Chart 38 EDWARD LIFESCIENCES CORP: SWOT ANALYSIS
Chart 39 LIVANOVA: OVERVIEW SNAPSHOT
Chart 40 LIVANOVA PLC: BUSINESS UNITS
Chart 41 LIVANOVA PLC: GEOGRAPHIC PRESENCE
Chart 42 LIVANOVA PLC: SWOT ANALYSIS
Chart 1 GLOBAL CARDIOVASCULAR DISEASES MARKET REVENUE, 2017 ($BILLION)
Chart 2 RESEARCH METHODOLOGY OF GLOBAL STRUCTURAL HEART DEVICES MARKET
Chart 3 STRUCTURAL HEART DEVICES MARKET REVENUE, 2017-2024 ($MILLION)
Chart 4 PORTERS 5 FORCES ON STRUCTURAL HEART DEVICES MARKET
Chart 6 STRUCTURAL HEART DEVICES MARKET SEGMENTATION
Chart 7 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
Chart 8 DRO - IMPACT ANALYSIS OF STRUCTURAL HEART DEVICES MARKET
Chart 9 KEY STAKEHOLDERS OF STRUCTURAL HEART DEVICES MARKET
Chart 10 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION)
Chart 11 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION)
Chart 12 STRUCTURAL HEART REPAIR DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION)
Chart 13 STRUCTURAL HEART REPLACEMENT DEVICE MARKET REVENUE, BY TYPE 2017-2024 ($MILLION)
Chart 14 STRUCTURAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017-2024 ($MILLION)
Chart 15 SURGICAL HEART REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 (%)
TRANSCATHETER VALVES
Chart 16 TRANSCATHETER VALVE REPLACEMENT DEVICES MARKET REVENUE, BY TYPES 2017 ($MILLION)
Chart 17 STRUCTURAL HEART DEVICES MARKET SEGMENT REVENUE BY END USERS, 2017 (%)
Chart 18 STRUCTURAL HEART DEVICES MARKET BY REGIONAL SEGMENTATION, 2017 (%)
Chart 19 STRUCTURAL HEART DEVICES MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION)
Chart 20 STRUCTURAL HEART DEVICES MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION)
Chart 21 STRUCTURAL HEART DEVICES MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION)
Chart 22 STRUCTURAL HEART DEVICES REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION)
Chart 23 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT
Chart 24 ABBOTT LABORATORIES: BUSINESS UNITS
Chart 25 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE
Chart 26 ABBOTT LABORATORIES: SWOT ANALYSIS
Chart 27 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 28 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS
Chart 29 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 30 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS
Chart 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 32 MEDTRONIC PLC: BUSINESS UNITS
Chart 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE
Chart 34 MEDTRONIC PLC: SWOT ANALYSIS
Chart 35 EDWARD LIFESCIENCES CORP: OVERVIEW SNAPSHOT
Chart 36 EDWARD LIFESCIENCES CORP: BUSINESS UNITS
Chart 37 EDWARD LIFESCIENCES CORP: GEOGRAPHIC PRESENCE
Chart 38 EDWARD LIFESCIENCES CORP: SWOT ANALYSIS
Chart 39 LIVANOVA: OVERVIEW SNAPSHOT
Chart 40 LIVANOVA PLC: BUSINESS UNITS
Chart 41 LIVANOVA PLC: GEOGRAPHIC PRESENCE
Chart 42 LIVANOVA PLC: SWOT ANALYSIS
